Massivemarkets

SEC Form 4

HealthEquity, Inc (HQY) insider trading

In the 12 months to Oct 24, 2026, 6 HQY insiders reported open-market sales of $4.2M across 11 filings; one EVP chief prod & strat officer bought $11.9K.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$4.2M
11 filings · 6 insiders
Open-market purchases
$11.9K
1 filing · Sunil Rajasekar, EVP Chief Prod & Strat Officer
Pre-arranged sales (10b5-1)
8 of 11
$2.7M of $4.2M sold (65%)

Who traded HQY, and when

  • Purchase
  • Sale
  • Sale, pre-arranged (10b5-1)

HQY daily close from Oct 24, 2025 to Oct 23, 2026, between $73.21 and $106.79, last $103.97. 11 sale and 1 purchase filings by 6 insiders, marked at their filing dates. Elimelech Rosner, EVP, CHIEF TECHNOLOGY OFFICER: sold $1.0M across 1 filing, first filed Dec 19, 2025, last Dec 19, 2025. Delano Ladd, EVP, General Counsel: sold $973.9K across 3 filings, first filed Nov 24, 2025, last Jun 1, 2026. Adrian T. Dillon, Director: sold $798.4K across 1 filing, first filed Aug 27, 2026, last Aug 27, 2026. Michael Henry Fiore, EVP, CHIEF COMMERCIAL OFFICER: sold $756.8K across 3 filings, first filed Jun 2, 2026, last Jul 14, 2026. Gayle Furgurson Wellborn, Director: sold $644.8K across 2 filings, first filed Dec 16, 2025, last Jun 1, 2026. Sunil Rajasekar, EVP Chief Prod & Strat Officer: sold $13.3K and bought $11.9K across 2 filings, first filed Oct 19, 2026, last Oct 19, 2026.

Largest mark · tap a row for others

Elimelech Rosner · EVP, CHIEF TECHNOLOGY OFFICER

Sale $1,046,090

10,959 shares at $95.45 avg

Filed Dec 19, 2025 · traded Dec 18

Close on filing date $95.50

HQY daily closelast $103.97

Elimelech Rosner · EVP, CHIEF TECHNOLOGY OFFICER

$1.0M sold

Delano Ladd · EVP, General Counsel

$973.9K sold

Adrian T. Dillon · Director

$798.4K sold

Michael Henry Fiore · EVP, CHIEF COMMERCIAL OFFICER

$756.8K sold

Gayle Furgurson Wellborn · Director

$644.8K sold

Sunil Rajasekar · EVP Chief Prod & Strat Officer

$13.3K sold$11.9K bought
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Has HealthEquity, Inc's CEO sold stock?

No. Scott Cutler (CEO) made no open-market sales filed as CEO in the last 12 months.

Open-market trades

12 filings in the last 12 months
InsiderRoleSoldBoughtFilingsPre-arranged (10b5-1)Last filed
Elimelech RosnerEVP, CHIEF TECHNOLOGY OFFICER$1.0M—1—
Delano LaddEVP, General Counsel$973.9K—3100% of sales
Adrian T. DillonDirector$798.4K—1100% of sales
Michael Henry FioreEVP, CHIEF COMMERCIAL OFFICER$756.8K—3100% of sales
Gayle Furgurson WellbornDirector$644.8K—234% of sales
Sunil RajasekarEVP Chief Prod & Strat Officer$13.3K$11.9K2—
Other insider activity (not market trades) · 54 records
  • Option exercises3 records
  • Tax withholding27 records
  • Grants and awards20 records
  • Gifts4 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

Build this yourself

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Agent prompt

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for HQY every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.